Phlow

Dr. Eric Edwards is co-founder and chief executive officer of Phlow Corp., a pioneering public benefit pharmaceutical corporation. As CEO, Dr. Edwards has assembled a world-class team committed to providing a solution to the broken essential medicines supply chain and over-reliance on foreign manufacturers for the Nation’s highest priority medicines.

Dr. Edwards was previously co-founder of Kaléo, Inc. a pharmaceutical company in Richmond, VA. During his 16 years at Kaléo, he held several executive management positions including Chief Science Officer where he was responsible for overall scientific strategy and all pharmaceutical development programs; Chief Medical Officer responsible for developing a medical affairs team and capability while operationalizing the Company’s clinical program strategy; and Vice President – Innovation, overseeing Kaleo’s research and development pipeline and overall new product strategy.

Dr. Edwards is the co-inventor of multiple marketed products, including AUVI-Q, epinephrine auto-injector for the treatment of allergic emergencies (anaphylaxis), is named on over 215 issued and patent-pending applications, and is a published author on numerous scientific publications.

Dr. Edwards also continues to serve his community by volunteering on a local rescue squad, including responding to 911 calls and training paramedics in pre-hospital emergency care.

Dr. Edwards. obtained his B.S. in Biology, Ph.D. in the Pharmaceutical Sciences, and Doctor of Medicine degrees at Virginia Commonwealth University/Medical College of Virginia.

Phlow's headquarters in Richmond, VA, United States

Org chart

Teams

Offices